Clinlogix acquires ikfe CRO
16 October 2013
Clinical research organization Clinlogix has expanded operations
in Europe with the acquisition of Mainz-based ikfe CRO GmbH.
Dr Marco Grenningloh PhD, Chief Operating Officer and Managing
Director of Clinlogix Europe, said, "This acquisition greatly
strengthens our strategic resources, knowledge base and
infrastructure in the largest pharmaceutical market in the world.
ikfe CRO was a highly respected regional service provider, and their
specialized expertise and in-depth understanding are further
enhancing our ability to provide knowledgeable, high quality
services to our clients around the globe."
From its base in Germany, Clinlogix Europe is a full service
organization that supports the development of drugs, devices and
diagnostics throughout Europe. It works in a variety of therapeutic
areas but has special expertise in diabetes, cardiovascular disease